admin

Three more biotechnology companies went public Thursday as startups continued to capitalize on strong demand for these offerings, a trend that’s giving life-sciences venture capitalists a much-needed lift.

Cellular Dynamics International Inc., Conatus Pharmaceuticals Inc. and Onconova Therapeutics Inc. debuted on Nasdaq Thursday. Their initial public offerings followed recent IPOs from venture-backed biotechs such as Agios Pharmaceuticals Inc., bluebird bio Inc., Esperion Therapeutics Inc., OncoMed Pharmaceuticals Inc. and Prosensa Holding BV.

Independence Blue Cross (IBC), Penn Medicine, and DreamIt Ventures today host “Demo Day” for 10 health care startup companies selected to participate in DreamIt Health, the first-ever Philadelphia-based health care accelerator. The event will be held from 10 a.m. to 2 p.m. at World Café Live! at 3025 Walnut Street in Philadelphia. The participants will each have seven minutes to present their business plans to potential investors and customers, mentors, and health care executives. Demo Day events are ideal opportunities for startups to begin raising money to launch their businesses and gauge interest among key audiences.

“As health care undergoes dramatic change, I believe that the health care companies that thrive will be those with a clear vision that move rapidly and innovate. The caliber of this group of entrepreneurs and the diverse health care companies they represent is very promising and we’re pleased to have played a part in helping them plan, develop, and now present their ideas,” said Daniel J. Hilferty, president and CEO of IBC. “We are committed to transforming our region into a magnet for health care innovation, investment and employment, and supporting bright, new ideas like those we nurtured through DreamItHealth will help us get there faster.”

Montgomery County’s Department of Economic Development is hoping to attract green businesses to the area with an incentive program that will reimburse investors as much as $25,000.

The Green Investor Incentive Program is now accepting applications from investors in businesses that provide green products or technologies. The program was approved in April by the County Council and County Executive Isiah Leggett appropriated $500,000 to fund the program.

Accelerators are all about discovering and mentoring talented entrepreneurs with good ideas for improving healthcare and other sectors. They make the right introductions to advisers, industry stakeholders and investors with the goal of improving the chances of their success. But when demo day ends, the team members are faced with the crucial question of how to sustain themselves as they advance the development of their companies. They need to figure out where their next sources of funding will come from.

Given poorly, criticism tends to lead to the criticized parties involved feeling like crap–and the criticizer looking like a jerk (or worse).

If you’re a psychologist, you’d call it reactance. If you’re a regular person, you’d call it a dick move.

“Proper email is a balance between politeness and succinctness,” entrepreneur-investor-author Guy Kawasaki tells Entrepreneur.com. “Less than five sentences is often abrupt and rude, more than five sentences wastes time.”

In this way, the email is like poem. A sonnet maybe, with the way its limitations have a funny way of granting freedom. Or maybe an epic poem, given the fact that we all write a novel’s worth of email every year. But would a missive by any other length read just as sweet?

The state of Maryland normally goes unnoticed in regards to the medtech and bioscience sectors when compared to California, Massachusetts and Minnesota. However, the state has the research facilities, governmental institutions and programs, corporate partnerships, funding and ambition to advance its biosciences marketplace into an international hub for medtech innovation.

At the heart of Maryland’s medical device and broader biotech industries is the state’s network of institutes and universities, which includes the National Institutes of Health, the National Institute of Standards & Technology, Johns Hopkins University and the University of Maryland. Each one of these entities boasts an array of specialized laboratories for the study of bioimaging, biomolecular modeling, drug delivery, biomaterials, MEMS, microfluidics and more.

What Is Baltimore Innovation Week?

Baltimore Innovation Week is a week-long celebration of technology and innovation in Baltimore. The annual week of events is intended to grow the impact of this innovative region through programming focused on technology, collaboration and improving Baltimore.

Last year, Baltimore Innovation Week 2012 had impact:

• More than 30 events from 25 partners with more than 1,500 attendees
• Startups and products launched, including NewsUp, Crowdstich and Easy WebContent’s Presenter.
• GBTC held Maryland’s first hackathon that featured representatives from city, state and federal government agencies.
• 15 projects launched as part of the latest Startup Weekend Baltimore, including winner TeamPassword.
• Venture for America unveiled plans to launch its fellowship program in Baltimore.
• TechBreakfast continued its growth as the region’s premiere startup demo event.
• Pitch Across Maryland brought Gov. O’Malley to Baltimore to show off his entrepreneurship-fueling work.
• The University of Maryland Biopark launched a new entrepreneurship demo series, starting with its incubated healthcare applications platform startup Analytics Informatics.
• Education Ignite welcomed more than 200 people to hear about the changing education climate in Baltimore.

In the downtown of the nation’s capital, there is a magnificent building of steel and glass that is now home to what may be a remarkable tech experiment.

The D.C. Public Library took an 11,000-square-foot space and installed 80 computers, including 16 Macs. A 3D printer was added as well as a machine that can print and bind a book from a file in just minutes. There are tablets of all types — Android, Windows, Apple — and e-reading devices, available to try out. It opened last week.

Regular marijuana use in adolescence, but not adulthood, may permanently impair brain function and cognition, and may increase the risk of developing serious psychiatric disorders such as schizophrenia, according to a recent preclinical study from the University of Maryland School of Medicine.

Researchers hope that the study, published in Neuropsychopharmacology — a publication of the journal Nature – will help to shed light on the potential long-term effects of marijuana use, particularly as lawmakers in Maryland and elsewhere contemplate legalizing the drug.